Toft-Nielsen MB, Madsbad S, Holst JJ (agosto de 2001). «Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes». The Journal of Clinical Endocrinology and Metabolism. 86 (8): 3853–60. PMID11502823. doi:10.1210/jcem.86.8.7743 !CS1 manut: Nomes múltiplos: lista de autores (link)
Meier JJ, Weyhe D, Michaely M; et al. (março de 2004). «Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes». Critical Care Medicine. 32 (3): 848–51. PMID15090972. doi:10.1097/01.CCM.0000114811.60629.B5 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Nannipieri M, Baldi S, Mari A; et al. (novembro de 2013). «Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones». The Journal of Clinical Endocrinology and Metabolism. 98 (11): 4391–9. PMID24057293. doi:10.1210/jc.2013-2538 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Mabilleau G, Mieczkowska A, Irwin N, Flatt PR, Chappard D (outubro de 2013). «Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor». The Journal of Endocrinology. 219 (1): 59–68. PMID23911987. doi:10.1530/JOE-13-0146 !CS1 manut: Nomes múltiplos: lista de autores (link)
Toft-Nielsen MB, Madsbad S, Holst JJ (agosto de 2001). «Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes». The Journal of Clinical Endocrinology and Metabolism. 86 (8): 3853–60. PMID11502823. doi:10.1210/jcem.86.8.7743 !CS1 manut: Nomes múltiplos: lista de autores (link)
Meier JJ, Weyhe D, Michaely M; et al. (março de 2004). «Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes». Critical Care Medicine. 32 (3): 848–51. PMID15090972. doi:10.1097/01.CCM.0000114811.60629.B5 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Presswala L, Shubrook J (abril de 2015). «What to do after basal insulin: 3 Tx strategies for type 2 diabetes». The Journal of family practice. 64 (4): 214-20. PMID25973447
Nannipieri M, Baldi S, Mari A; et al. (novembro de 2013). «Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones». The Journal of Clinical Endocrinology and Metabolism. 98 (11): 4391–9. PMID24057293. doi:10.1210/jc.2013-2538 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Mabilleau G, Mieczkowska A, Irwin N, Flatt PR, Chappard D (outubro de 2013). «Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor». The Journal of Endocrinology. 219 (1): 59–68. PMID23911987. doi:10.1530/JOE-13-0146 !CS1 manut: Nomes múltiplos: lista de autores (link)